Bevatas 300mg Solution for Infusion
Inclusive of all taxes
Free Express Cold-Chain Delivery
Temperature-controlled dispatch across India within 4 to 24 hours.
Order through WhatsAppFinancial Assistance Available
Contact our oncology support team to check your eligibility for manufacturer patient assistance programs (PAP) for Bevatas 300mg Solution for Infusion.
About this medicine
Bevatas 300mg Solution for Infusion (Bevacizumab (300mg))is a prescription oncology medicine. Below is educational product information — follow your doctor's advice for dose and use.
Bevatas 300mg Injection is an anticancer medicine consisting of the active ingredient Bevacizumab. This medicine is developed to prevent the growth of tumors. It is indicated along with other chemotherapy drugs to treat metastatic breast cancer, brain cancer, cervical cancer, kidney cancer, lung cancer, and colorectal cancer. It is also used to treat cancers of the ovary, fallopian tube or primary peritoneal cancer. Use effective birth control during the treatment and for at least six months after the last dose. Bevatas 300mg Injection is not recommended for adolescents and children under the age of 18. Discuss with your doctor about the preservation of ovaries if you are planning for pregnancy in the near future as this medicine may cause fertility issues in women. It would be best to avoid breastfeeding your baby as this medicine may interfere with the growth and development.
Quick Facts
Generic Name
Bevacizumab (300mg)
Dosage Form
Solution
Prescription Status
Doctor's Rx Required
What if you miss a dose?
If you miss a dose of Bevatas 300mg Solution for Infusion, please consult your doctor.
Uses of Bevatas 300mg Solution for Infusion
Side Effects of Bevatas 300mg Solution for Infusion
Oncology medicines should be administered strictly under medical supervision. Inform your oncologist immediately if you experience adverse symptoms.
Clinical Safety Advice for Bevatas 300mg Solution for Infusion
Follow expert clinical guidelines regarding interactions, precautions, and medical conditions when taking Bevatas 300mg Solution for Infusion.
It is not known whether it is safe to consume alcohol with Bevatas 300mg Solution for Infusion. Please consult your doctor.
Bevatas 300mg Solution for Infusion may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Bevatas 300mg Solution for Infusion is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Bevatas 300mg Solution for Infusion may cause side effects which could affect your ability to drive.Sleepiness and fainting have been reported with Bevatas 300mg Solution for Infusion and this may impair your ability to drive.
Bevatas 300mg Solution for Infusion is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Bevatas 300mg Solution for Infusion may not be needed in these patients. Please consult your doctor.
Bevatas 300mg Solution for Infusion is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Bevatas 300mg Solution for Infusion may not be needed in these patients. Please consult your doctor.
Cold-Chain Temperature Protocol
Temperature-controlled cold-chain dispatch for Bevatas 300mg Solution for Infusion across India, with express delivery in Delhi NCR, Noida, and Ghaziabad.
Temperature Monitoring
Sourced from certified cold-storage warehouses.
Insulated Transit
Dispatched in gel-ice thermal insulated boxes.
Rx Verification
Prescription validated prior to cold dispatch.
Frequently Asked Questions
Medical information standards
Educational product information for Bevatas 300mg Solution for Infusion. Not a substitute for advice from your treating doctor or healthcare provider.
- Reviewed by
- Nitin Kumar, D.Pharm (UPPC Reg: 63405)Lead Registered Pharmacist · 11 years clinical experience · Drug licence RLF21DL2025001406, RLF20DL2025001420. See our medical review policy.
- Content dates
- Catalogue copy is re-checked under our editorial standards. Pricing and stock update more often at checkout.
- Business address
- Vyloo Technologies Pvt. Ltd.
10251, F/F, Library Road, Nawab Ganj, Delhi G.P.O., Delhi, North Delhi- 110006, Delhi, IndiaGSTIN 07AAKCV0933E1ZF, 09AAKCV0933E1ZB. More on our drug licence page.
Authoritative references
- CDSCO (India) — Central Drugs Standard Control Organisation — Indian drug regulator
- Ministry of Health & Family Welfare — Government of India health ministry
- WHO Essential Medicines — World Health Organization essential medicines lists
- National Health Portal (India) — Government of India National Health Portal
Have questions about your cancer prescription?
Our licensed oncology pharmacists are available to assist with medicine availability, cold-chain handling, and prescription verification.